Interleukin-6, Tumor Necrosis Factor alpha and Metabolic Disorders in Youth

Konstantinos Kitsios, Maria Papadopoulou, Konstantina Kosta, Nikolaos Kadoglou, Dimitrios Chatzidimitriou, Fani Chatzopoulou, Maria Papagianni, Kiriaki Tsiroukidou, Nikolaos Malisiovas

Abstract


Background: To compare Interleukin-6 (IL-6) and Tumor Necrosis Factor a (TNFalpha) levels in obese and overweight youth to their normal weight counterparts. Furthermore, we compared IL-6 and TNFalpha levels in obese and overweight individuals with and without additional metabolic disorders such as Metabolic Syndrome (MS), Non Alcoholic Fatty Liver Disease (NAFLD) and prediabetes.

Methods: All 54 consecutive obese children and adolescents with Body Mass Index (BMI) >= 95th centile and 50 overweight children and adolescents with 85th £ BMI < 95th were screened for MS, prediabetes and NAFLD. Serum IL-6 and TNFalpha were measured in all the participants and in 40 normal weight age-matched individuals (controls).

Results: IL-6 levels were increased in obese children and adolescents compared to the controls (2.4 ± 1.9 vs 1.0 ± 0.5 pg/mL, P < 0.001) and to the overweight participants (1.5 ± 1.2 pg/mL, P < 0.014). IL-6 was also elevated in overweight compared to normal weight youth (P = 0.027) and in youth with MS compared to their counterparts without MS (2.9 ± 1.9 vs 1.7 ± 1.5 pg/mL, P = 0.013). TNFalpha levels were comparable between obese and normal weight (2.1 ± 1.2 vs 2.0 ± 0.6 pg/mL respectively, P = 0.805), overweight and normal weight (2.0 ± 1.0 pg/mL, P = 0.834), obese and overweight participants (P = 0.997). Obese and overweight individuals with NAFLD had elevated levels of TNFalpha compared to their counterparts with normal liver (2.7 ± 1.1 vs 1.0 ± 1.0 pg/mL, P = 0.005).

Conclusions: Youth with excessive weight have elevated IL-6 levels, especially in the presence of MS. TNFalpha levels, although comparable between normal weight and excessive weight youth, are raised in overweight and obese individuals with NAFLD.




J Endocrinol Metab. 2012;2(3):120-127
doi: https://doi.org/10.4021/jem111w


Keywords


Obesity; Metabolic syndrome; Prediabetes; Non Alcoholic Fatty Liver Disease; Inflammation

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.